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A synthetic nonadecapeptide (IL 19) derived from a sequence of v-myb was covalently bound to haemocya- 
nin and used for immunization. Anti-IL 19 serum immunoprecipitated a 75 kDa protein in the lysate of 
metabolically labelled chicken and murine thymus cells. Presaturation of the serum with IL 19 abolished 
this immunoprecipitation, thus indrcating that the product of c-myb in both chicken and murine thymuses 
is the 75 kDa protein (p75’*“yb). Anti IL 19 serum also precipitated p48 - ”myb in the lysate of nonproducer 
myeloblasts. 
Anti-peptide antibody Immunoprecipitation c-myb protein p48wn”h (Chicken, Mouse) 
1. INTRODUCTION 
Over 20 different v-one have been explored and 
corresponding c-one have been isolated and, in 
most cases, structurally analysed. The genomes of 
a broad spectrum of vertebrate species contain one 
or more copies of c-myb [l-3], whose transcription 
is restricted to hematopoietic organs [4-61. This 
contrasts sharply with the ubiquitous expression of 
many other c-enc. There is apparently an inverse 
correlation between c-myb expression and the in- 
itiation of terminal differentiation [7,8]. A large 
Abbreviations: KLH, keyhole limpet haemocyanin; 
AEV, avian erythroblastosis virus; AMV, avian myelo- 
blastosis virus; SDS-PAGE, SDS-poiyacrylamide gel 
electrophoresis; c-one, cellular oncogene; v-myb, trans- 
forming sequence of avian myeloblastosis virus; Pr76gag, 
precursor of gag proteins; cDNA complementary DNA; 
BDB, bis-diazotized benzidine; ~48, protein of 48 kDa; 
v-one, viral transforming sequence; c-myb, cellular 
homologue of the transforming sequence of avian 
myeloblastosis virus 
portion of chicken c-myb [9], and the c-myb cDNA 
[IO], have been molecularly cloned and sequenced. 
The avian c-myb protein product has been iden- 
tified as p75c-“yb y immunoprecipitation of the 
lysate of AEV-transformed erythroblasts with an- 
tibodies directed against a part of v-myb expressed 
in a procaryotic vector [l l] and has been found to 
be located in the nucleus [ 121, The protein product 
of c-myb, however, has not been unequivocally 
detected in non-transformed avian cells. 
Murine c-myb cDNA has also been molecularly 
cloned and sequenced [13]. However, the protein 
product of c-myb (mouse) was not detected. 
AMV is an oncogenic retrovirus which 
transforms myelomonocytic cells in vitro and 
causes myeloblastic leukaemia in chicks [14]. The 
gene responsible for this transformation has been 
designated v-myb. Apparently, it has emerged 
through transduction of several c-myb exons into 
a retroviral genome [2,9]. The product of v-myb is 
a protein of 45-48 kDa (~48”~~~) [ 11,15,16]. It is 
located in the nucleus [12,17] and binds to DNA 
1181. 
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In this study, we identified the c-myb protein 
product in avian and murine thymus cells by means 
of antibodies directed against a synthetic 
nonadecapeptide hapten. The ~48’~~~~ was also 
detected in the lysate of nonproducer transformed 
myeloblasts. 
2. MATERIALS AND METHODS 
KLH was from Calbiochem, [3SS]methionine 
(>30 TBq/mmol) from Amersham and tryptose 
phosphate broth from Difco. 
The AMV-transformed GM 727 line of chicken 
nonproducer myeloblasts (producers of only 
noninfectious virions) [19] was kindly provided by 
T. Graf; the cells were grown at 37°C in Eagle’s 
MEM [20] supplemented with 10% tryptose 
phosphate broth, 5% heat-inactivated foetal calf 
serum and 1% chicken serum. A short-term tissue 
culture of chicken thymus cells was prepared from 
the freshly explanted thymi of l-3 weeks old 
leukosis-free Brown Leghorns [21]. Short-term 
tissue cultures of mouse thymus cells were 
prepared from 2-4-week-old Balb/c mice. For 
labelling, cells were suspended (1 x 10’ 
myeloblasts/ml or 2.5 x 10’ thymus cells/ml) in 
Eagle’s MEM (minus methionine) with 1% dia- 
lysed foetal calf serum and 1% dialysed chicken 
serum and incubated for 20 min. [3SS]Methionine 
was then added (9.25 MBq/ml) and the incubation 
continued for 120 min. The average incorporations 
(in lo6 cpm) per lo6 cells were as follows: 
myeloblasts, 4.5; chicken thymocytes, 1.5; mouse 
thymocytes, 1. 
The synthetic peptide used for immunization 
was composed of 19 amino acids (IL 19). The posi- 
tion of IL 19 is: in v-myb, 789-845 bp [22]; 
V812-V868 bp [9]; in c-myb, C3715-C3771 bp [9]; 
1075-1131 bp [IO]; 874-930 bp [I3]. IL I9 was 
covalently bound to KLH with BDB [23] (9 mol IL 
19 per mol KLH) and 5 rabbits were immunized 
with the IL IPKLH conjugate. The 6th rabbit was 
immunized with BDB-treated KLH without pep- 
tide. The final sera from rabbits immunized with 
IL 19-KLH were designated l-5, serum from the 
6th rabbit was control. Details concerning the 
choice of IL 19, its synthesis and covalent binding 
to KLH will be published separately. The pro- 
cedures of immunization, immunoprecipitation, 
SDS-PAGE and processing of gels by fluoro- 
graphy are described in [16]. In a typical experi- 
ment, lysates of 1 x lo6 myeloblasts or 1 x 10’ 
thymus cells were preimmunoprecipitated with 5 ,J 
of control serum (2 h, 18°C). The supernatant was 
then immunoprecipitated with 5 pl of immune 
serum. Presaturation of 5 pl of serum 4 was done 
with 1.5 pg of a peptide or 50 pg of KLH. 
3. RESULTS 
The synthetic peptide (IL 19) used as hapten to 
elicit myb-specific antibodies was composed of 19 
amino acids in the following sequence: Ile-Gln- 
Arg-His-Tyr-Thr-Asp-Glu-Asp-Pro-Glu-Lys-Glu- 
Lys-Arg-Ile-Lys-Glu-Leu. For immunization, IL 
19 was covalently bound to carrier protein KLH. 
We used all the final antisera for immunoprecipita- 
tion of metabolically labelled lysates of GM 727 
cells, and p48 was immunoprecipitated (fig.1). Im- 
munoprecipitation was the most effective by serum 
4 (lane 4). Control serum did not precipitate ~48 
(lane 6) while anti-p27 serum immunoprecipitated 
Pr76g”g (lane 7). The specificity of p48 im- 
munoprecipitation by anti-IL 19 serum (fig.2, lane 
3) was proved by abolition following presaturation 
of the serum with IL 19 (lane 4). Presaturation of 
the serum with peptide SV 17 (lane 5), also derived 
Fig.1. Fluorogram of a gel slab after electrophoresis of 
proteins from AMV myeloblasts immunoprecipitated by 
sera 1-5. The lysates were immunoprecipitated with sera 
l-5 (lanes l-5, respectively), control serum (lane 6) and 
1.5 pl of anti-p27 serum (lane 7). The im- 
munoprecipitated proteins were subjected to SDS-7.5% 
PAGE. On the left are the positions and sizes of 
molecular mass markers. Arrows on the right indicate 
the positions of Pr76gag and p4tYmyb. 
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Fig.2. Fluorogram of a gel slab after electrophoresis of 
proteins from AMV myeloblasts immunoprecipitated by 
presaturated serum 4. Lysates of GM 727 cells were im- 
munoprecipitated with: control serum (lane l), anti-p27 
serum (lane 2), serum 4 (lane 3), serum 4 presaturated 
with IL 19 (lane 4), serum 4 presaturated with SV 17 
(lane 5), serum 4 presaturated with KLH (lane 6). Im- 
munoprecipitated proteins and molecular mass markers 
(lane 7) were subjected to SDS-IO% PAGE. Arrows on 
the left indicate the positions of Pr76Kag and p48”mmyb. 
from a v-myb sequence but different from IL 19 
[16], was without any effect on immunoprecipita- 
tion of ~48; so was presaturation with KLH (lane 
6). Thus, the immunoprecipitation of ~48 in the 
lysate of AMV-transformed myeloblasts by anti-IL 
19 serum was specific and the protein precipitated 
was therefore ~48”~~~~. Control serum did not 
precipitate it (lane 1). Anti-p27 serum im- 
munoprecipitated Pr768ag (lane 2). 
We next metabolically labelled a short-term 
chicken thymus tissue culture and lysates of it were 
immunoprecipitated by anti-IL 19 serum (fig.3). It 
followed from the pattern of immunoprecipitated 
proteins that there was specific precipitation of ~75 
by anti-IL 19 serum and, hence that the chicken c- 
myb protein product p7Ymyb was detected in non- 
transformed chicken cells. Of sera 1-5, only serum 
4 immunoprecipitated ~75. This was in agreement 
with the precipitation of the v-myb protein (fig.1, 
Fig.3. Fluorogram of a gel slab after electrophoresis of 
immunoprecipitated proteins from chicken thymus. The 
lysates were immunoprecipitated with: control serum 
(lane l), serum 4 (lane 2), serum 4 presaturated with IL 
19 (lane 3), serum 4 presaturated with SV 17 (lane 4), 
serum 4 presaturated with KLH (lane 5). Im- 
munoprecipitated proteins and molecular mass markers 
(lane 6) were subjected to SDS-7-15% gradient PAGE. 
Arrow on the left indicates the positions of ~75’~~~~. 
lane 4). On some gels, ~75’~~~~ migrated as a 
doublet. Neither band was recognized by IL 19 
presaturated anti-IL 19 serum. 
The nucleotide sequence from which IL 19 was 
derived is contained in mouse mRNA but its 
translation product is not known [ 131. We 
prepared a short-term tissue culture from the 
murine thymus and immunoprecipiated 
metabolically labelled lysates of it with control 
serum and serum 4 (fig.4). ~75 was only 
precipitated by serum 4 (cf. lanes 1 and 2). 
Presaturation of serum 4 with IL 19 abolished this 
immunoprecipitation (lane 3). It therefore seems 
that in murine thymus c-myb is expressed and that 
its product, p75c-myb (mouse), does not substantial- 
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4 
Fig.4. Fluorogram of a gel slab after electrophoresis of 
immunoprecipitated proteins from mouse thymocytes. 
The lysates were immunoprecipitated with control serum 
4 (lane l), serum 4 (lane 2) and serum 4 presaturated 
with IL 19 (lane 3). Immunoprecipitated proteins and 
molecular mass markers (lane 4) were subjected to 
SDS-7.5% PAGE. Arrow on the left indicates the posi- 
tion of ~75~~~~~. 
ly differ in molecular mass from the chicken c-myb 
protein product. 
4. DISCUSSION 
The synthetic nonadecapeptide hapten IL 19 was 
derived from a sequence of cloned v-myb [22]. It 
is also contained in the c-myb sequence, but sur- 
prisingly in c-myb (both avian and murine) there is 
Asn instead of Thr in position 6. We do not know 
if the Thr substituting the more polar Asn in this 
sequence could be of any importance for 
tumorigenicity by ~48”-~~~, but the change is ap- 
parently of little importance for the specificity of 
antibodies. 
We had 5 final anti-IL 19 serum samples at our 
disposal. They precipitated ~48”~~~ at different in- 
tensity, with serum 4 being the most effective. 
The expression of c-myb in chicken tissues on 
the level of mRNA has been estimated [6]. Max- 
imal expression is in AEV-transformed 
erythroblasts and in thymus cells. The translation 
product in transformed cells is ~75 [ 111. We at- 
tempted to detect the c-myb protein product in the 
chicken thymus with anti-IL 19 serum. The ~75 
was immunoprecipitated by anti-IL 19 serum; by 
this serum after presaturation with a heterologous 
peptide or the carrier protein; but not after its 
presaturation with peptide IL 19. This 
demonstrated that the c-myb protein product in 
the chicken thymus and erythroblasts is one of 75 
kDa. 
The sequence of IL 19 is contained in the 
presumptive protein product of c-myb (mouse), 
and c-myb transcripts are found in mice at much 
higher levels in thymic cells and cells of the 
erythroid lineage than elsewhere [4]. We also 
labelled mouse thymus cells in tissue culture and 
immunoprecipitated their lysate with anti-IL 19 
serum. ~75 was detected on the fluorogram posi- 
tioned in good agreement with its predicted size 
v31. 
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ADDENDUM 
When the experimental part of this work was 
finished we learned [24] that AMV-transforming 
proteins were detected with antibodies directed 
against a peptide with a sequence partially overlap- 
ping with ours. 
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